Spineart, eCential Robotics earn FDA nod for robotic-assisted spine surgery application

Spineart and eCential Robotics today announced the receipt of FDA 510(k) clearance for the use of an application for robotic navigation.

The FDA cleared the Spineart Perla TL application for use with the new eCential Op.n robotic navigation platform. Both companies say the clearance marks a significant milestone in advancing robotic-assisted spine surgery

Spineart’s Perla app further integrates the Perla TL Open and MIS screw systems with the eCential Op.n platform. It offers a Spineart navigation-specific interface and dedicated Spineart navigated instruments. This aims to enhance surgical precision and procedural workflow. Additionally, the companies say the integration expands the range of 3D C-arms compatible with the system.

Sign up for Blog Updates